Astrana Health Inc (ASTH) Reports Disappointing Q3 Earnings

1 min readBy Investing Point Editorial

Astrana Health Inc (ASTH) reported disappointing financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) stood at $0.01, falling significantly short of Wall Street's consensus estimate of $0.45. Revenue matched expectations at $1.0 billion, but the overall performance did not meet analyst forecasts.

The results reflect ongoing challenges within the company and the broader market conditions. Astrana Health, headquartered in Alhambra, California, is a physician-centric, technology-powered healthcare management firm that employs 1,900 full-time staff. With segments including Care Partners, Care Delivery, and Care Enablement, the company supports over 20,000 providers in delivering coordinated care.

Astrana Health will host an earnings conference call to discuss these results and provide further insights into its operational performance. Investors are encouraged to review the full earnings release and listen to management's commentary for a comprehensive understanding of the quarter's performance and future outlook.

Looking ahead, the company is scheduled to report its next earnings on 4 August 2026, with EPS estimated at $0.459 and revenue projected at $0.9 billion.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Earnings Reports

Explore more earnings reports or view detailed analysis for ASTH stock.